Volume Stonkers | Intra-Cellular surged 34.07%, Johnson & Johnson plans largest biotech acquisition in two years

Generado por agente de IAStock Spotlight
lunes, 13 de enero de 2025, 4:31 pm ET2 min de lectura
BTC--
MS--
NVDA--
TSLA--
NVIDIA, ranked first in trading volume, fell 1.97% with a trading volume of $26.618 billion. NVIDIA criticized the Biden administration's chip quota proposal as "overreaching" and announced a breakthrough in physical AI.

Tesla, ranked second, rose 2.17% with a trading volume of $25.232 billion. Tesla announced the implantation of its brain-machine interface chip in a third test subject and received an optimistic valuation from Morgan Stanley, which raised its price target.

Apple, in third place, dropped 1.03% with a trading volume of $11.481 billion. Apple is facing a £1.5 billion legal claim in the UK, and its global market share is under threat.

Microsoft, ranked fourth, fell 0.42% with a trading volume of $7.203 billion. Microsoft expanded its partnership with HCLTech to revolutionize call centers using generative AI and formed a new AI team.

Meta, in fifth place, declined 1.22% with a trading volume of $6.458 billion. Meta is under pressure from a looming TikTok ban, and its target price was raised by YAYUN shares.

Amazon, ranked sixth, decreased 0.22% with a trading volume of $5.896 billion. Amazon's diversity strategy differs from other tech giants, and it participated in NRG Energy's stock transaction.

Broadcom, in seventh place, rose 0.44% with a trading volume of $5.198 billion. Broadcom entered a new $7.5 billion revolving credit facility, terminating its 2021 credit agreement.

MicroStrategy, ranked eighth, increased 0.15% with a trading volume of $4.946 billion. MicroStrategy resumed Bitcoin purchases, acquiring approximately 2,530 Bitcoins.

Intra-Cellular, in ninth place, surged 34.07% with a trading volume of $4.563 billion. Johnson & Johnson plans to acquire Intra-Cellular for billions, marking the largest biotech acquisition in nearly two years.

Advanced Micro Devices (AMD), ranked tenth, rose 1.10% with a trading volume of $4.477 billion. Goldman Sachs maintained a hold rating on AMD, noting that laptop shipments exceeded expectations.

Palantir, in eleventh place, dropped 3.39% with a trading volume of $4.367 billion. Palantir underperformed last week, was reduced by ARK, and market sentiment remains pessimistic.

Alphabet A, ranked twelfth, fell 0.54% with a trading volume of $4.113 billion. Google Cloud formed a new AI sales team and conducted layoffs to improve project efficiency.

UnitedHealth, in thirteenth place, rose 4.00% with a trading volume of $3.406 billion. Morgan Stanley maintained a buy rating on UnitedHealth and raised its price target.

TSMC, ranked fourteenth, dropped 3.31% with a trading volume of $3.254 billion. The White House's decision to restrict AI chip exports affected TSMC's stock price, raising market concerns about AI chip export restrictions.

Visa, in fifteenth place, decreased 0.29% with a trading volume of $2.880 billion. Visa's target price was raised by AllianceBernstein, and it offers merchant refund application services.

Eli Lilly, ranked sixteenth, fell 0.26% with a trading volume of $2.872 billion. Eli Lilly plans to acquire Scorpion and expects its weight-loss drug to be approved in early 2026.

Alphabet C, in seventeenth place, declined 0.46% with a trading volume of $2.511 billion. Google announced the transfer of the AI Studio team to DeepMind to enhance efficiency.

Netflix, ranked eighteenth, rose 0.31% with a trading volume of $2.476 billion. Macquarie maintained an outperform rating on Netflix, with analysts optimistic about its long-term dominance in the streaming sector.

JPMorgan Chase, in nineteenth place, increased 1.81% with a trading volume of $2.421 billion. JPMorgan Chase provided disaster forbearance support to mortgage clients affected by the Los Angeles wildfires.

Micron Technology, ranked twentieth, fell 4.31% with a trading volume of $2.134 billion. Micron was affected by the White House's AI chip export restrictions, but UBS maintained its buy rating.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios